Corporate, M&A and regulatory affairs involving pharmaceutical and medical devices industries. He regularly advises both local and foreign clients on mergers and acquisitions of listed and unlisted businesses, and joint ventures. He also regularly provides advice on general corporate and commercial matters, and regulatory affairs including licensing, joint R&D, dealings with HCPs, labeling/promotion, off-label use and AE reporting.
Admitted in Japan (1994), New York (2000).
Dai-ni Tokyo Bar Association (Japan), 1994
Japan Chapter "Life Sciences 2018" (co-author) (Getting the Deal Through, 2018); Others
University of Tokyo (LLB, 1992); Stanford Law School (JSM, 1999)